Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: Data from the NEOZOTAC trial (BOOG 10-01)

Charehbili, A.; Hamdy, N.A.T.; Smit, V.T.H.B.M.; Kessels, L.; Bochove, A. van; Laarhoven, H.W. van; ... ; Dutch Breast Canc Res Grp BOOG (2016)

Article / Letter to editor

• Breast cancer
• Neoadjuvant chemotherapy
• 25-Hydroxy-vitamin D
• Zoledronic acid

• All authors: Charehbili, A.; Hamdy, N.A.T.; Smit, V.T.H.B.M.; Kessels, L.; Bochove, A. van; Laarhoven, H.W. van; Putter, H.; Kranenbarg, E.M.K.; Leeuwen-Stok, A.E. van; Hoeven, J.J.M. van der; Velde, C.J.H. van de; Nortier, J.W.R.; Kroep, J.R.; Dutch Breast Canc Res Grp BOOG
• Date: 2016-02-28
• Journal: The Breast
• Volume: 25
• Pages: 69 - 74
• DOI: doi:10.1016/j.breast.2015.10.005